Latest News

Date Title Topic
30 May 2014 New Guidelines for Planning and Developing Cancer Registries in Low- and Middle-Income Settings Cancer prevention
28 May 2014 European Medicines Agency Adopted a Change to an Indication for Eribulin Anticancer agents & Biologic therapy
27 May 2014 European Medicines Agency Recommends to Extend Indications for Ofatumumab Haematologic malignancies - Anticancer agents & Biologic therapy
26 May 2014 European Medicines Agency Recommends to Refuse a Change to the Marketing Authorisation for Bevacizumab Central nervous system malignancies - Anticancer agents & Biologic therapy
23 May 2014 ESMO Press Release: ESMO, UICC, NCD Alliance and Other Endorsing Partners Issue Palliative Care Statement at WHA
23 May 2014 European Medicines Agency Recommends Granting a Marketing Authorisation for Obinutuzumab Haematologic malignancies - Anticancer agents & Biologic therapy
21 May 2014 Study Calls for Revisiting Cardiac Screening Guidelines for Survivors of Childhood Cancer Cancer in Special Situations
20 May 2014 A Mathematical Biologist Against Cancer Translational research - Central nervous system malignancies - Lung and other thoracic tumours
19 May 2014 New Science of Toxgnostics Personalised medicine - Anticancer agents & Biologic therapy
Ovarian Cancer
13 May 2014 Hypertension Related to VEGF Inhibitors Anticancer agents & Biologic therapy
09 May 2014 IMPAKT 2014 News: Combination of mTOR and AKT Inhibitors in Patients with Advanced Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
09 May 2014 IMPAKT 2014 News: Molecular Subtype of a Breast Cancer Relapse Influences Patient Post-Relapse Survival Breast cancer - Pathology/Molecular biology - Translational research
09 May 2014 IMPAKT 2014 News: Adoption of Multi-gene Assays in Hormone Receptor-Positive, HER2-Negative Breast Cancer Breast cancer - Personalised medicine